JUNB and JUND in Urological Cancers: A Literature Review

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• JUNB and JUND are transcriptional factors (TFs) integral to cellular processes.
• They are part of the JUN TF family, downstream effectors of MAPKs, and play roles in carcinogenesis and metastasis.
• These TFs form the AP-1 complex, influencing normal and cancerous cells, with context-dependent tumor-suppressing or oncogenic functions.

Purpose of the Study:

• To review the roles of JUNB and JUND in urological cancers (prostate, bladder, renal, testicular).
• To discuss shared and distinct expression patterns, mechanisms, and clinical implications of JUNB and JUND across these cancers.
• To highlight the potential of JUNB and JUND as targets for cancer prevention, diagnosis, prognosis, and treatment.

Main Methods:

• Narrative review of existing literature on JUNB and JUND in urological cancers.
• Analysis of commonalities and differences in TF expression, function, and clinical relevance.
• Exploration of potential therapeutic strategies targeting JUNB and JUND.

Main Results:

• JUNB and JUND exhibit context-dependent roles, acting as both tumor suppressors and oncogenes in urological malignancies.
• Expression patterns and mechanisms of JUNB and JUND vary across prostate, bladder, renal, and testicular cancers.
• Their involvement in cancer progression and therapeutic resistance is significant.

Conclusions:

• JUNB and JUND are critical regulators in urological cancers with multifaceted roles.
• Understanding their specific functions in different urological malignancies is crucial for targeted therapies.
• JUNB and JUND represent promising targets for improving prevention, diagnosis, prognosis, and treatment strategies in urological cancers.